Cong Lai
Impact in
-
- Cancer-related molecular mechanisms research
-
- Kidney Stones and Urolithiasis Treatments
- Ferroptosis and cancer prognosis
- Prostate Cancer Treatment and Research
Papers in
-
- Kidney Stones and Urolithiasis Treatments 4
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Kewei Xu (19 shared papers)Peter G. Shields (1 shared paper)Zhuohang Li (15 shared papers)Kuiqing Li (12 shared papers)Juanyi Shi (10 shared papers)Zhuang Tang (6 shared papers)Cheng Liu (7 shared papers)Kaixuan Guo (7 shared papers)
In The Last Decade
Cong Lai
37 papers receiving 276 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 58
- Pulmonary and Respiratory Medicine 90
- Obstetrics and Gynecology 11
- Molecular Biology 90
- Oncology 28
Countries citing papers authored by Cong Lai
This map shows the geographic impact of Cong Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Lai more than expected).
Fields of papers citing papers by Cong Lai
This network shows the impact of papers produced by Cong Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Lai. The network helps show where Cong Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 35 | |
| 2 | 2020 | 20 | |
| 3 | 2023 | 20 | |
| 4 | 2021 | 20 | |
| 5 | 2023 | 16 | |
| 6 | 2021 | 14 | |
| 7 | 2020 | 14 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 9 | |
| 11 | 2023 | 9 | |
| 12 | 2024 | 9 | |
| 13 | 2023 | 8 | |
| 14 | 2016 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2023 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2024 | 6 | |
| 20 | 2024 | 5 |
About Cong Lai
Cong Lai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Pediatrics, Perinatology and Child Health, having authored 41 papers that have together received 283 indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (4 papers), RNA modifications and cancer (3 papers), Pediatric Urology and Nephrology Studies (2 papers), Urological Disorders and Treatments (2 papers), Circular RNAs in diseases (2 papers), Energy Load and Power Forecasting (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (58 citations), Pulmonary and Respiratory Medicine (90 citations), Obstetrics and Gynecology (11 citations), Molecular Biology (90 citations) and Oncology (28 citations). Cong Lai has collaborated with scholars based in China, Hong Kong and Bulgaria. Frequent co-authors include Kewei Xu, Peter G. Shields, Zhuohang Li, Kuiqing Li, Juanyi Shi, Zhuang Tang, Cheng Liu, Kaixuan Guo, Kaiwen Li and Jintao Hu. Their work appears in journals such as Cancer Medicine, BMC Cancer, Frontiers in Oncology, International Urogynecology Journal and BMC Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.